epc-20200206
0001096752FALSE00010967522020-02-062020-02-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________

FORM 8-K
______________________

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): February 6, 2020
epc-20200206_g1.jpg
EDGEWELL PERSONAL CARE COMPANY

(Exact name of registrant as specified in its charter)

Missouri
1-15401
43-1863181
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)

6 Research Drive, Shelton, Connecticut 06484
(Address of principal executive offices)
        
203-944-5500
(Registrant's telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareEPCNew York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company held its annual meeting of shareholders (the “Annual Meeting”) on Thursday, February 6, 2020. Of the 54,300,084 shares outstanding and entitled to vote at the Annual Meeting, 50,165,818 shares were represented in person or by proxy, constituting a quorum.
The final results for each of the matters submitted to a vote of shareholders at the Annual Meeting are as follows:
Proposal 1: Management's nominees for director were elected to serve until the Annual Meeting of Shareholders to be held in 2021 or until their respective successors are elected and qualified, by the votes set forth in the table below:
NomineeForAgainstAbstainBroker Non-Votes
Robert W. Black 45,673,858  792,979  60,967  3,638,014  
George R. Corbin 45,979,703  379,006  169,095  3,638,014  
Daniel J. Heinrich 45,491,738  959,820  76,246  3,638,014  
Carla C. Hendra45,382,901  1,063,435  81,468  3,638,014  
R. David Hoover45,480,276  970,744  76,784  3,638,014  
John C. Hunter, III45,662,196  790,165  75,443  3,638,014  
James C. Johnson44,471,845  1,980,960  74,999  3,638,014  
Rod R. Little 46,248,696  201,921  77,187  3,638,014  
Joseph D. O’Leary 46,092,381  358,198  77,225  3,638,014  
Rakesh Sachdev45,636,253  812,390  79,161  3,638,014  
Gary K. Waring 45,799,439  653,110  75,255  3,638,014  

Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2020 was ratified by the shareholders by the votes set forth in the table below:

ForAgainstAbstain
48,788,8541,313,57363,391
Proposal 3: The Company's executive compensation, as described in the Company's Proxy Statement, was approved by the non-binding advisory votes of the shareholders as set forth in the table below:

ForAgainstAbstainBroker Non-Votes
35,576,42110,844,515106,8683,638,014

Proposal 4: The Company's Amended and Restated 2018 Stock Incentive Plan, as described in the Company's Proxy Statement, was approved by the votes of the shareholders as set forth in the table below:


ForAgainstAbstainBroker Non-Votes
42,324,3341,574,0382,629,4323,638,014

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.

Exhibit No.Description
101Cover page information from Edgewell Personal Care Company's Current Report on Form 8-K filed on February 10, 2020, formatted in iXBRL (Inline Extensible Business Reporting Language).





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
EDGEWELL PERSONAL CARE COMPANY
By:  /s/ Marisa B. Iasenza    
Marisa B. Iasenza
Chief Legal Officer

Dated: February 10, 2020